Case Study: AZothBio speeds drug discovery with Rescale

AZothBio speeds genome and peptide discovery from 5 days to 24 hours with Rescale

AZothBio, a bio-pharmaceutical startup, faced a challenge when its on-premises high performance computing (HPC) hardware could no longer support the capacity and complexity of its proprietary deep learning algorithms for drug discovery. To meet urgent public health needs and enhance R&D agility, the company sought a solution from Rescale that was simple, scalable, and could handle its complex custom applications.

By implementing Rescale's cloud HPC platform, AZothBio gained access to pre-installed software and the best-fit GPU hardware on AWS. This allowed the team to successfully run its epitope prediction AI models and other research workloads. The solution delivered by Rescale had a measurable impact, reducing the time for genome and peptide discovery analysis from 5 days to within 24 hours per analysis, significantly accelerating lead identification.

AZothBio